葡萄糖皮质体受体的多元化途径
Andrea Alegre-Martí1,2, Alba Jiménez-Panizo1,2,3,4, Agustina L Lafuente5
1Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona (UB), Barcelona 08028, Spain.
Nucleic acids research
|October 21, 2025
概括
研究人员发现了葡萄糖皮质体受体 (GR) 结合体结合域 (GR-LBD) 的新二元结构,澄清了其多元化和功能. 这一发现有助于更好地理解一般性抗葡萄糖皮质激素耐药性.
科学领域:
- 结构生物学是结构生物学.
- 分子细胞生物学分子细胞生物学
- 药理学 药理学 是一个学科.
背景情况:
- 葡萄糖皮质体受体 (GR) 是炎症和免疫抑制疾病的关键药物标.
- 全长型GR (FL-GR) 的精确寡合体构造对其生物活性至关重要,但仍有争议.
- 了解GR结构是开发有效疗法和治疗耐药性的关键.
研究的目的:
- 阐明葡萄糖皮质体受体 (GR) 的功能性寡合体构造.
- 为了呈现一种新型的晶体结构的激素因子结合的GR-LBD).
- 为了研究已识别的二聚体在受体多元化和细胞活性中的生物相关性.
主要方法:
- 进行X射线晶体学,以确定激动剂结合的GR-LBD的结构.
- 分子动力学模拟用于分析受体行为.
- 交叉连接质谱学用于研究蛋白质相互作用.
- 光显微镜和活细胞中的转录组分析,以评估生物相关性.
主要成果:
- 一种与激素结合的GR-LBD的新晶体结构揭示了非正规二元体的八个副本.
- 这种二聚体在FL-GR多元化中的生物相关性通过使用多种实验技术得到证实.
- 在不同的组合中,GR-LBD二元体的自我结合为FL-GR多元化提供了洞察力.
- 提出了多域GR结构和寡合化的综合模型.
结论:
- 该研究提出了一个新的GR-LBD二分体结构和FL-GR的详细的寡合化途径.
- 该模型协调了GR的现有结构和功能数据.
- 这些发现为人们更深入地了解了一般化的葡萄皮质激素耐药性,这是影响GR信号的罕见疾病.
更多相关视频
相关概念视频
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
Amplifying Signals via Second Messengers
8.4K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
8.4K
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
MAPK Signaling Cascades
7.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.9K


